Update on Repatha (Evolocumab) - a Medication Used to Treat High Low Density Lipoprotein CholesterolApproved by the FDA in August 2015, Repatha (Evolocumab) is a subcutaneous injection used to [...]
FDA Recommends Restricting the Use of Fluoroquinolones Due to Potential Side EffectsThe FDA has recently released a statement indicating that the use of systemic fluoroquinolones should be [...]
AlixaRx Makes Enhancements to Therapeutic Interchange ProgramAlixaRx is pleased to announce that we have expanded our Therapeutic Interchange (TI) program. This program allows prescribers to [...]
